Bayesian Capital Management’s Advent Technologies ADN Stock Holding History
Bought
Maintained
Sold
Other funds holding ADN
PCM
Bayesian Capital Management's ADN Position: Q1 2023 in Review
Bayesian Capital Management sold out of Advent Technologies (ADN) in Q1 2023, closing a stake of 567 shares — an estimated $30.8K sold.
Bayesian Capital Management first reported a position in ADN in Q4 2022 and held it in 1 quarter. The position peaked at $30.8K in Q4 2022. 36 funds tracked by Wall St. Rank hold ADN as of Q1 2023.
- Bayesian Capital Management reported no remaining Advent Technologies position as of Q1 2023 after selling out during the quarter.
- Bayesian Capital Management sold 567 Advent Technologies shares in Q1 2023, an estimated $30.8K.
- Bayesian Capital Management first reported a position in Advent Technologies in Q4 2022 and held it in 1 quarter.
- Bayesian Capital Management's Advent Technologies position peaked at $30.8K in Q4 2022.
- 36 funds tracked by Wall St. Rank held Advent Technologies as of Q1 2023.
Based on Bayesian Capital Management's 13F filing for Q1 2023, filed 15 May 2023.